How does the internal medical device development process work at large medtechs? with Rebecca Whitney, ZimVie
WATCH or LISTEN below, thank you for supporting MedtechWOMEN Talks!
In this episode of MedtechWOMEN Talks, Rebecca Whitney, SVP, Global Spine President, ZimVie dives deep into what it takes to bring innovative medical solutions to market in a large medtech OEM, weighing the benefits of internal product development against strategic external partnerships.
The episode shines a light on the diligent process behind medical device product development, taking into consideration global market nuances, regulatory challenges, and the balance between in-house innovations and external collaborations. Whitney underscores the value of rigorous review stages, which sometimes require difficult decisions like ceasing investment in long-term, costly projects.
TL;DR – Key takeaways:
- Tough decisions, like halting a project, are necessary for the betterment of patient care and resource allocation.
- Product development incorporates feedback from patients, surgeons, and salesforces to ensure that solutions are practical and market-appropriate.
- Strategic external partnerships can optimize development by leveraging outside expertise, allowing large medtechs like ZimVie to focus on their core strengths.
Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical!
Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.
Thank you for listening to MedtechWOMEN Talks!
WATCH Now:
LISTEN Now:
